Ricardo Bernales, MD in Berwyn, IL - Allergy & Immunology

Ricardo Bernales, MD is a Allergy & Immunology physician based in Berwyn, Illinois. Ricardo Bernales is licensed to practice in Illinois (license number 36057501) and his current practice location is 3240 S Oak Park Ave, Berwyn, Illinois. He can be reached at his office (for appointments etc.) via phone at (708) 795-7760.

NPI number for Ricardo Bernales is 1952343097 and his current mailing address is 3240 S Oak Park Ave, Berwyn, Illinois. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1952343097.

Contact Information

	Ricardo Bernales, MD
	3240 S Oak Park Ave, Berwyn, IL 60402
	(708) 795-7760
	(708) 788-8141

Physician's Profile

Full Name	Ricardo Bernales
Gender	Male
Speciality	Allergy & Immunology
Location	3240 S Oak Park Ave, Berwyn, Illinois
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1952343097
Provider Enumeration Date: 06/12/2006
Last Update Date: 07/17/2008

Medical Identifiers

Medical identifiers for Ricardo Bernales such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1952343097	NPI	-	NPPES
36057501	Other	IL	IL LIC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207K00000X	Allergy & Immunology	36057501 (Illinois)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ricardo Bernales is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ricardo Bernales, MD 3240 S Oak Park Ave, Berwyn, IL 60402 Ph: (708) 795-7760	Ricardo Bernales, MD 3240 S Oak Park Ave, Berwyn, IL 60402 Ph: (708) 795-7760

News Archive

For many working low-income residents, health law's promise is still unaffordable

Stateline examines the difficulty for many working families to buy insurance while KHN spends time at a California hospital to survey how some without insurance try to afford care. Other news coverage on health law outreach and enrollment looks at narrow networks in some plans and an effort in Connecticut to attract consumers.

SHIFT study finds Ivabradine reduces heart failure risk

Ivabradine, a selective If inhibitor already investigated for its effects in coronary artery disease and left ventricular dysfunction, significantly lowers the risk of heart failure, according to results of the SHIFT study (Systolic Heart failure treatment with the If inhibitor ivabradine Trial).

NIH awards La Jolla Institute $12.6M to develop San Diego's first Center for RNAi screening

The La Jolla Institute for Allergy & Immunology will develop San Diego's first Center for RNAi screening - a breakthrough genomics technology that will further enhance San Diego's reputation as a national research leader and provide the local biomedical community ready access to the Nobel-Prize winning technology.

FDA tackles illegal hydrocodone products

The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved prescription drug products containing hydrocodone, a narcotic widely used to treat pain and suppress coughs.

Ricardo Bernales, MD - Allergy & Immunology in Berwyn, IL